Related Experiment Video
Updated: Feb 12, 2026

Molecular Modulation by Lentivirus-Delivered Specific shRNAs in Endoplasmic Reticulum Stressed Neurons
Published on: April 24, 2021
Bexarotene Modulates Retinoid-X-Receptor Expression and Is Protective Against Neurotoxic Endoplasmic Reticulum Stress
Yogita Dheer1, Nitin Chitranshi2, Veer Gupta3
1Faculty of Medicine and Health Sciences, Macquarie University, F10A, 2 Technology Place, North Ryde, NSW, 2109, Australia. yogitadheer@gmail.com.
Abstract:
Retinoid X-receptors (RXRs) are members of the ligand-dependent transcription factor family of nuclear receptors that have gained recent research focus as potential targets for neurodegenerative disorders. Bexarotene is an RXR pharmacological agonist that is shown to be neuroprotective through its effects in promoting amyloid beta (Aβ) uptake by the glial cells in the brain. This study aimed to evaluate the dose-dependent effects of bexarotene on RXR expression in SH-SY5Y neuroblastoma cells and validate the drug effects in the brain in vivo. The protein expression studies were carried out using a combination of various drug treatment paradigms followed by expression analysis using Western blotting and immunofluorescence. Our study demonstrated that bexarotene promoted the expression of RXR α, β and γ isoforms at optimal concentrations in the cells and in the mice brain. Interestingly, a decreased RXR expression was identified in Alzheimer's disease mouse model and in the cells that were treated with Aβ. Bexarotene treatment not only rescued the RXR expression loss caused by Aβ treatment (p < 0.05) but also protected the cells against Aβ-induced ER stress (p < 0.05) and pro-apoptotic BAD protein activation (p < 0.05). In contrast, higher concentrations of bexarotene upregulated the ER stress proteins and led to BAD activation. Our study revealed that these downstream neurotoxic effects of high drug concentrations could be prevented by pharmacological targeting of the TrkB receptor. The ER stress and BAD activation induced by high concentrations of bexarotene were rescued by the TrkB agonist, 7,8 dihydroxyflavone (p < 0.05) while TrkB inhibitor CTX-B treatment further exacerbated these effects. Together, these findings suggest a cross-talk of TrkB signalling with downstream effects of bexarotene toxicity and indicate that therapeutic targeting of RXRs could prevent the Aβ-induced molecular neurotoxic effects.
Insights
Bexarotene, a Retinoid X receptor (RXR) agonist, shows neuroprotective effects by increasing RXR expression and reducing amyloid beta toxicity. High doses can cause neurotoxicity, but TrkB receptor targeting may prevent this.
Area of Science:
- Neuroscience
- Molecular Biology
- Pharmacology
Background:
- Retinoid X receptors (RXRs) are nuclear receptors investigated for neurodegenerative disorders.
- Bexarotene, an RXR agonist, demonstrates neuroprotection by enhancing amyloid beta (Aβ) uptake.
- Dysregulation of RXR expression is implicated in Alzheimer's disease pathology.
Purpose of the Study:
- To investigate the dose-dependent effects of bexarotene on RXR expression in neuroblastoma cells and mouse brains.
- To determine if bexarotene can counteract Aβ-induced neurotoxicity.
- To explore the role of TrkB receptor signaling in bexarotene's downstream effects.
Main Methods:
- SH-SY5Y neuroblastoma cells and mouse models were treated with varying concentrations of bexarotene.
- Protein expression of RXR isoforms, ER stress markers, and BAD was analyzed using Western blotting and immunofluorescence.
- Experiments involved co-treatments with Aβ, TrkB agonist (7,8-dihydroxyflavone), and TrkB inhibitor (CTX-B).
Main Results:
- Optimal bexarotene concentrations increased RXR α, β, and γ expression in cells and mouse brains.
- Bexarotene rescued Aβ-induced loss of RXR expression, ER stress, and BAD activation.
- High bexarotene concentrations induced ER stress and BAD activation, which were mitigated by TrkB receptor activation.
Conclusions:
- Bexarotene exhibits dose-dependent effects on RXR expression and neuroprotection.
- Targeting RXRs with bexarotene may offer a therapeutic strategy against Aβ-induced neurotoxicity.
- TrkB receptor signaling interacts with bexarotene's downstream effects, suggesting a potential mechanism for managing drug toxicity.
Related Concept Videos
Endoplasmic Reticulum
The Endoplasmic Reticulum
Smooth Endoplasmic Reticulum
The ER provides optimal conditions for synthesizing steroid hormones and lipids, such as phospholipids and triglycerides. Traditionally, lipid metabolism was considered to be a smooth ER function. However, there is no direct evidence to prove that rough ER is completely excluded from lipid...
Directing Proteins to the Rough Endoplasmic Reticulum
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway

